InvestorsHub Logo

1plus1

10/04/20 12:15 PM

#27299 RE: suny66 #27298

WOOOOOOOW !!!!! THIS COULD BE THE " MERGER OF THE LIFE TIME" FASTEN YOUR SEATBELT MONDAY !!!!!!!!

Jisep

10/04/20 12:29 PM

#27301 RE: suny66 #27298

Good point SUNY

UncleBilly

10/04/20 12:30 PM

#27302 RE: suny66 #27298

Why $ENZC is the future Big Pharma and Monoclonal Antibodies are the FUTURE of Medical Care: (this is very big; please sticky if you deem worthy)

Different types of monoclonal antibodies treat different types of diseases.

Just last week, a BOMBSHELL report came out from Gates Foundation affiliate "WELLCOME" called "Expanding Access to Monoclonal Antibody-Based Products: A Global Call to Action"

In a nutshell, MONOCLONAL ANTIBODY treatments are the FUTURE of medical care because they provide superior results without toxic side effects of Big Pharma's pharmaceuticals. They basically use your own body to heal itself organically without toxic side effects.

All sources, including the report and very interesting case studies can be found in this DD thread on Twitter. KNOW WHAT YOU HOLD! This is the future:

https://twitter.com/UncleBillyMoney/status/1312595840637300736?s=20

Dr. Cotropia is clearly a pioneer in monoclonal antibodies discovery dating back prior to 1989. He's been there from the beginning and now is his time as commercial access is finally being granted as Big Pharma is spread thin and can no longer fight the advancement of what President Trump called "miracle treatments sent down from God" just last night (10/3/20).

There are big issues at play here.

The efficacy and commercial viability of monoclonal antibodies has been known for some time but mass commercial use would have upset Big Pharma's profits because monoclonal antibodies treatments would have replaced some of their cash cow pharmaceuticals in their pipeline.

Note, BioClonetics is in late stages with HIV treatments but they also have several other treatments in the pipeline (see below). This could genuinely be the next Big Pharma, replacing antiquated special interests that do not always serve the health and needs of the people. Current Big Pharma views us as customers, rather than patients; monoclonal antibody treatments will usher in a new era and revolutionize medical care and there will be big winners in this space. $ENZC will be one of them. Get ready.

"BioClonetics is a company with proprietary technology for producing fully human monoclonal antibodies (mAbs) against infectious diseases including HIV, rabies, influenza A, influenza B, tetanus, and diphtheria. BioClonetics proprietary methodology for producing fully human MONOCLONAL ANTIBODIES may be used to produce therapeutic fully human MONOCLONAL ANTIBODIES for treating many infectious diseases including the #Coronavirus""